Company: PIII
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001832511-25-000013
Chunk: 87

Company: P3 Health Partners Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 87
---
3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

Three Months Ended June 30,Six Months Ended June 30,2025202420252024OPERATING REVENUE:Capitated revenue$351,724 $374,306 $721,241 $758,440 Other patient service revenue4,064 4,851 7,772 9,205 TOTAL OPERATING REVENUE355,788 379,157 729,013 767,645 OPERATING EXPENSE:Medical expense351,350 365,171 723,393 747,228 Premium deficiency reserve(5,967)(3,397)(12,929)(2,397)Corporate, general and administrative expense23,295 26,610 48,294 54,011 Sales and marketing expense151 414 332 736 Depreciation and amortization21,083 21,693 42,135 43,232 TOTAL OPERATING EXPENSE389,912 410,491 801,225 842,810 OPERATING LOSS(34,124)(31,334)(72,212)(75,165)OTHER INCOME (EXPENSE):Interest expense, net(10,145)(5,436)(18,870)(9,692)Mark-to-market of stock warrants2,002 8,673 5,324 8,889 Other583 291 901 628 TOTAL OTHER INCOME (EXPENSE)(7,560)3,528 (12,645)(175)LOSS BEFORE INCOME TAXES(41,684)(27,806)(84,857)(75,340)INCOME TAX PROVISION(1,981)(968)(3,054)(3,040)NET LOSS(43,665)(28,774)(87,911)(78,380)LESS: NET LOSS ATTRIBUTABLE TO REDEEMABLE NON-CONTROLLING INTEREST(23,303)(16,754)(47,069)(47,660)NET LOSS ATTRIBUTABLE TO CONTROLLING INTEREST$(20,362)$(12,020)$(40,842)$(30,720)NET LOSS PER SHARE (Note 9):Basic$(6.23)$(4.40)$(12.52)$(12.02)Dil